CSAAI 2026 Educational Meeting: A Midsummer Night’s Wheeze
It is an exciting time in the field of allergy and immunology. This CME/CE program is designed to allow attendees to continue exploring the field. Covered topics include Immune Deficiency, SCID, Asthma, Food Allergy, Eosinophilic Conditions and more!
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the California Society of Allergy, Asthma & Immunology (CSAAI). The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 6.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 6.75 contact hours.
No commercial support was received for this activity.
Target Audience
Practicing allergists
Primary care physicians
Allied healthcare professionals
Learning Objectives
At the conclusion of this activity learners should be able to…
1. Appraise current and emerging therapies, including oral and intralymphatic immunotherapy, in terms of safety, adherence, and long-term outcomes compared to strict avoidance.
2. Apply epidemiological insights and age-linked patterns of food allergy to guide individualized patient management across the life course.
3. Consolidate evidence on the identification and management of uncontrolled and severe asthma, incorporating phenotype, endotype, and biomarker assessment to guide individualized treatment.
4. Review the treatments used to treat primary Immunodeficiency
CSAAI 2026 Annual Meeting - A Midsummer's Night Wheeze
Program Agenda
All Education Sessions to be held in Huntington South
Exhibits and Coffee Breaks to be held in Huntington North
SATURDAY, JUNE 27
8:00 am-2:15 pm Registration
8:30-9:30 am Exhibits & Continental Breakfast
9:35-9:50 am Welcome & Overview , Raffi Tachdjian, MD, MPH, CSAAI President
9:50-10:40 am Fresh Air: What’s New in Moderate to Severe Asthma / Q&A, Praveen Akuthota, MD
Saturday Practice Management Symposium featuring Jennifer Kuehn, CPC
brought to you by California Society of Allergy, Asthma and Immunology and the
American College of Allergy, Asthma and Immunology
10:40-11:30 am 2026 Coding Update / Q&A, Jennifer Kuehn, CPC
11:30 am-12:40 pm Lunch Break and Exhibits
12:40-1:30 pm Updates in Anaphylaxis Diagnosis and Management / Q&A, Julie Wang, MD
1:30-2:20 pm Primary Immunodeficiency Primer Update / Q&A, Ramsay Fuleihan, MD
2:20 pm Adjourn
SUNDAY, JUNE 28
7:00-7:50 am Continental Breakfast & Exhibits
7:50-8:00 am Overview, Javed Sheikh, MD, CSAAI Program Director
8:00-8:50 am Newborn Screening for SCID and other Immunodeficiency Disorders / Q&A, Ramsay Fuleihan, MD
8:50-9:40 am Eosinophilic Lung Diseases / Q&A, Praveen Akuthota, MD
9:40-10:20 am Coffee Break & Exhibits
10:20-11:10 am The Latest in Treatment Options for Food Allergy / Q&A, Julie Wang, MD
11:10-11:20 am Closing Remarks, Raffi Tachdjian, MD, MPH, CSAAI President
11:20 am Adjourn
All relevant financial relationships with ineligible companies have been mitigated.
Praveen Akuthota, MD – Speaker
Consultant: AstraZeneca, Biopharma, Gilead, Sanofi
Researcher: 4D Molecular Therapeutics, AstraZeneca, Recode, Sanofi
Matthew Bowdish, MD – Planner
Advisor, Researcher, Speaker: GSK
Ramsay Fuleihan, MD – Speaker
Speaker: Grifols
Sonal Patel, MD – Planner
Speaker: Regeneron, Sanofi
Raffi Tachdjian, MD, MPH – Planner, Moderator
Advisor: Astria, Biocryst, CSL Behring, Kalvista, Pharming, Pharvaris, Takeda
Independent contractor: Astria, Biocryst, CSL Behring, Ionis, Kalvista, Pharing, Pharvaris, Takeda
Speaker: ARS, AstraZeneca, Biocryst, CSL Behring, Grifols, GSK, Lilly, Novartis, Pharming, Regeneron/Sanofi, Takeda
Julie Wang, MD – Speaker
Independent contractor: DBV Technologies, Siolta
The following have no relevant financial relationships with ineligible companies to disclose:
Karol Anderson – Planner
Jennifer Kuehn, CPC – Speaker
Myngoc Nguyen, MD – Planner
Javed Sheikh, MD – Planner, Moderator
Suzanne Teuber, MD – Planner
Available Credit
- 6.75 AMA PRA Category 1 Credit™
- 6.75 Attendance
- 6.75 CBRN

Facebook
X
LinkedIn
Forward